Assay for determining the presence or amount of newly synthesized antibodies

Abstract

The present invention provides a method of determining the presence or amount of newly synthesised antibody in a sample in response to an immunogen by detecting the released antibodies or parts thereof in a sample containing lymphocytes which have been disrupted whereby to release the synthesised antibodies or parts thereof associated with said lymphocytes whereby to determine the presence or amount of newly synthesised antibody in said sample, methods of diagnosis using said method and kits for performing the method. The method may also be modified to allow detection of non-specific infection indicators.

1 - 20 . (canceled) 
     
     
         21 . A method of determining whether newly synthesized target antibody is present in a body fluid sample in response to an immunogen comprising:
 detecting said target antibodies or parts thereof that have been released from lysed lymphocytes, whereby the presence of newly synthesized target antibody from the lymphocytes indicates whether newly synthesized antibodies are in the body fluid sample,   wherein said lymphocytes are obtained from a whole blood sample containing lymphocytes from a subject suspected of undergoing an immune response whereby the lymphocytes are in the acute phase of antibody synthesis.   
     
     
         22 . The method of  claim 21  further comprising the step of lysing the lymphocytes to release said target antibodies or parts thereof from said lymphocytes. 
     
     
         23 . The method of  claim 21 , wherein said blood sample is peripheral blood. 
     
     
         24 . The method of  claim 21 , wherein the sample is not incubated to promote synthesis and/or secretion of antibodies prior to the method. 
     
     
         25 . The method of  claim 22 , wherein the lymphocytes are lysed by using physical disruption means or cell-disrupting buffers or solutions. 
     
     
         26 . The method of  claim 21 , wherein the target antibodies or parts thereof are detected by binding to one or more antigens which recognize said antibodies or parts thereof. 
     
     
         27 . The method of  claim 21 , wherein the released target antibodies are detected by means of a solid phase binding assay. 
     
     
         28 . The method of  claim 27 , wherein the solid phase of said solid phase binding assay carries one or more antigens recognized by the target antibody or antibodies or parts thereof to be detected. 
     
     
         29 . The method of  claim 27 , wherein the solid phase of said solid phase binding assay carries one or more antibodies, which recognize the target antibody or target antibodies or parts thereof to be detected. 
     
     
         30 . The method of  claim 21 , wherein the method is performed on neonate or infant blood samples for distinguishing between newly synthesized antibodies and passively transferred maternal antibodies. 
     
     
         31 . The method of  claim 22 , wherein prior to lysing the lymphocytes, or after lysis but prior to the detection step, said sample is stored at about 4° C. or less. 
     
     
         32 . The method of  claim 21 , wherein said blood sample for preparing lymphocytes for use in the method, has a volume of less than 1 ml. 
     
     
         33 . The method of  claim 21 , wherein the lymphocytes are directly isolated from said blood sample. 
     
     
         34 . The method of  claim 21 , wherein the detecting step is performed by immunoassay. 
     
     
         35 . The method of  claim 34 , wherein the immunoassay is enzyme linked immunosorbent assay. 
     
     
         36 . The method of  claim 29 , wherein one or more antigens, recognized by the target antibodies immobilized on said solid phase, are contacted with said solid phase. 
     
     
         37 . The method of  claim 27 , wherein one or more antibodies, which recognize target antibodies immobilized on said solid phase, are contacted with said solid phase. 
     
     
         38 . The method of  claim 29 , wherein one or more antibodies, which recognize target antibodies immobilized on said solid phase, are contacted with said solid phase. 
     
     
         39 . The method as claimed in  claim 21 , wherein the detection step comprises the addition of an enzyme-antibody conjugate or an enzyme-antigen conjugate, and the addition of a soluble substrate, wherein said soluble substrate yields a spectrophotometrically detectable signal. 
     
     
         40 . The method as claimed in  claim 21 , wherein the target antibodies or parts thereof are detected by binding to one or more antigens which recognize said antibodies or parts thereof and wherein said method is additionally performed using a negative control antigen. 
     
     
         41 . The method of  claim 27 , wherein multiple solid phases are employed each bearing a different target antigen, which recognizes a different target antibody. 
     
     
         42 . The method of  claim 21  further comprising determining the amount of a newly synthesized a target antibody comprising:
 comparing said antibody binding to antibody binding in control and/or reference samples, whereby to obtain a determination of the amount of newly synthesized antibody in response to said immunogen.   
     
     
         43 . The method of  claim 21 , wherein the newly synthesized antibody is synthesized in vivo. 
     
     
         44 . The method of  claim 42 , wherein the newly synthesized antibody is synthesized in vivo. 
     
     
         45 . The method of  claim 21 , wherein the newly synthesized antibody is an antigenically active antibody, which has been produced or synthesized by and within a lymphocyte in vivo as part of an ongoing immune response. 
     
     
         46 . The method of  claim 42 , wherein the newly synthesized antibody is an antigenically active antibody, which has been produced or synthesized by and within a lymphocyte in vivo as part of an ongoing immune response